444 WEST LAKE STREET, SUITE 1700, CHICAGO, IL
Market cap: $58.1M (12/25/2025)
Price: $1.57
Biotechnology Announces $1.51 Million Private Placement
Ateganosine Surges Ahead with Breakthrough Momentum as Pivotal Phase 3 Trial Initiates
Takes Aim at a $50B Immunotherapy Market with Breakthrough Telomere-Targeting Approach
Biotechnology Highlights Ongoing Momentum of Ateganosine Clinical Program at SITC 2025
CEO Presents Telomere Targeting Efficacy at Romania’s 2025 Smart Diaspora Conference on Oncology Research and Innovation
.2
Presents Trial in Progress Poster at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
Other Events, Press Release
Q3
Q2
Q1
FY 2024
FY 2023
Notice of Exempt Offering of Securities
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
Definitive Proxy Statement
PRE 14A
Statement of Changes in Beneficial Ownership
Amended Schedule 13D - Ownership Report
Amended Statement of Changes in Beneficial Ownership
Correspondence
Submission Upload
Free Writing Prospectus